ICT Module VIII
Upon completion of the module, the participant will:
- Learn the importance of fatty acid balance including the importance of fatty acid supplementation in the cancer patient
- Understand nutrients that can add augmenting cancer therapies
- Know nutritional depletions caused by chemotherapy
- Learn nutrients that can decrease side effects of radiation without affecting therapy
- Identify nutrients that inhibit cancer-dependent enzymes
- Learn nutrients that can cause apoptosis of cancer cells
- Know nutrients that inhibit inflammation
- Review the literature on nutrients that can inhibit tumor invasion
- Learn nutrients that can block angiogenesis
- Know nutrients that have anti-hormone effects
- Identify nutrients that can promote immune enhancement such as beta-glucans, thymus protein extract, mushroom extracts, MGN-3, colostrum, lactoferrin, astragalus, mistletoe extract along with others
- Identify nutrients that improve barrier strength and reduce tumor invasion
- Understand the role of antioxidant use with chemotherapy and radiation
- Know nutrients that decrease the effectiveness of chemotherapy and radiation
- Learn nutrients that increase the effectiveness of chemotherapy and radiation
- Understand the importance of reducing tumor cell glutathione levels with whey protein intake
- Understand the importance of hydration in the cancer patient
- Value the role that melatonin can play in the treatment of cancer
- Understand the nutrient and herb interactions with conventional cancer therapies
- Learn the action of vitamin D metabolites on cancer cells
Schedule:
| Holistic vs. Biomedical Models of Palliative Care; Management of Cancer Pain with Integrated Botanicals and Pharmaceuticals; Role of Cannabis in Palliative Cancer Care | Dwight McKee, MD | 2 hrs |
| Novel Integrated Approaches for Cancer Patients with Advanced Disease | Eric Marsden, ND | 4 hrs |
| Overview of Integrative Palliative Care, Part 1 | Akbar Khan, MD | 1 hr |
| Overview of Integrative Palliative Care, Part 2 | Akbar Khan, MD | 1 hr |
| Metabolic Therapy with Dichloroacetate | Akbar Khan, MD | 1 hr |
| Anti-Angiogenic Therapy with Copper Chelation | Akbar Khan, MD | 1 hr |
| Immunotherapy with Low Dose Naltrexone | Akbar Khan, MD | 1 hr |
| Novel Integrated Approaches for Cancer Patients with Advanced Disease(Continued) | Eric Marsden, ND | 1 hr |
| Differentiating Agents | Akbar Khan, MD | 1 hr |
| Novel Integrated Approaches for Cancer Patients with Advanced Disease(Continued) | Eric Marsden, ND | 1 hr |
| Novel Integrated Approaches for Cancer Patients with Advanced Disease(Continued) | Eric Marsden, ND | ½ hr |
| Euthanasia and Assisted Suicide | Akbar Khan, MD | 1 hr |
| Advanced Pain Assessment and Management | Akbar Khan, MD | ½ hr |
| Advanced Pain Assessment and Management (Continued) | Akbar Khan, MD | ½ hr |
| Non Parenteral Palliative Care | Paul Anderson, ND | 1 hr |
| Parenteral Therapies in Palliative Care and Quality of Life | Paul Anderson, ND | 2 ½ hr |
| Parenteral Uses of Ascorbate: Research Outcomes and Implications for Cancer Care | Paul Anderson, ND | 2 hr |
| Novel Parenteral Compounds in Oncology | Paul Anderson, ND | 1 hr |
| Salinomycin: Targeting the Cancer Stem Cells | Mark Rosenberg, MD | 1 hr |
